2025 Regular SessionTexas Legislature

HB1496

Legislative Summary

Relating to the use, possession, delivery, or manufacture of testing equipment that identifies the presence of fentanyl, alpha-methylfentanyl, or any other derivative or controlled substance analogue of fentanyl.

Demographic Impact

Overall analysis of equity impact

80% Positive
High ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

12/3/2024
Filed
House of Representatives
3/11/2025
Read first time
House of Representatives
3/11/2025
Referred to Public Health
House of Representatives

Status Information

Current Status
Introduced(12/3/2024)
Chamber
House of Representatives
Committee
Public Health(House of Representatives)

Sponsors

Democrat: 1

Primary Sponsor

Erin Zwiener
Erin Zwiener
Democrat

Documents

Introduced
Bill Text12/3/20247.0 KB